HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Philip N Hawkins Selected Research

Serum Amyloid P-Component

1/2018Repeat doses of antibody to serum amyloid P component clear amyloid deposits in patients with systemic amyloidosis.
9/2015Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component.
6/2013Monitoring systemic amyloidosis using MRI measurements of the extracellular volume fraction.
10/2012Isolation and characterization of pharmaceutical grade human pentraxins, serum amyloid P component and C-reactive protein, for clinical use.
11/2010Antibodies to human serum amyloid P component eliminate visceral amyloid deposits.
3/2010Sustained pharmacological depletion of serum amyloid P component in patients with systemic amyloidosis.
5/2009Molecular dissection of Alzheimer's disease neuropathology by depletion of serum amyloid P component.
4/2006Diagnostic performance of 123I-labeled serum amyloid P component scintigraphy in patients with amyloidosis.
9/2005Quantitative high-resolution microradiographic imaging of amyloid deposits in a novel murine model of AA amyloidosis.
1/2003Novel pharmacological strategies in amyloidosis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Philip N Hawkins Research Topics

Disease

120Amyloidosis
05/2022 - 06/2002
64Immunoglobulin Light-chain Amyloidosis
01/2022 - 05/2003
30Amyloid Plaque
12/2021 - 10/2002
15Cardiomyopathies (Cardiomyopathy)
01/2022 - 03/2004
13Transthyretin-Related Hereditary Amyloidosis
12/2021 - 06/2005
13Inflammation (Inflammations)
09/2017 - 02/2004
11Chronic Kidney Failure (Chronic Renal Failure)
05/2022 - 11/2005
11Cryopyrin-Associated Periodic Syndromes
01/2021 - 09/2002
9Proteinuria
01/2020 - 10/2002
8Renal Insufficiency (Renal Failure)
01/2020 - 03/2004
7Familial Amyloidosis (Hereditary Amyloidosis)
05/2017 - 05/2003
6Aortic Valve Stenosis (Aortic Stenosis)
01/2022 - 04/2013
6Paraproteinemias (Monoclonal Gammopathy)
01/2021 - 07/2003
6Fever (Fevers)
02/2013 - 09/2002
5Infections
05/2022 - 01/2009
5Polyneuropathies (Polyneuropathy)
06/2021 - 03/2004
5Familial Amyloid Neuropathies (Familial Amyloid Polyneuropathy)
01/2020 - 10/2004
4Alzheimer Disease (Alzheimer's Disease)
01/2018 - 04/2006
4autosomal dominant familial Periodic fever
01/2011 - 01/2002
3Hypertrophy
01/2021 - 03/2015
3Disease Progression
09/2018 - 06/2013
3Body Weight (Weight, Body)
01/2018 - 08/2006
3Necrosis
12/2012 - 04/2006
2Bundle-Branch Block (Fascicular Block)
01/2021 - 10/2020
2Restrictive Cardiomyopathy
01/2020 - 01/2018
2Schnitzler Syndrome
01/2018 - 02/2013
2Rare Diseases (Rare Disease)
06/2016 - 09/2013
2Nephrotic Syndrome (Syndrome, Nephrotic)
06/2014 - 12/2006
2Cardiovascular Diseases (Cardiovascular Disease)
02/2014 - 04/2006
2Infarction (Infarctions)
09/2013 - 04/2006
2Myocardial Infarction
09/2013 - 04/2006
2Acute-Phase Reaction
10/2012 - 11/2005
2Heart Diseases (Heart Disease)
10/2012 - 10/2004
2Stroke (Strokes)
11/2010 - 04/2006
2Familial Mediterranean Fever (Periodic Disease)
01/2009 - 06/2007
2Exanthema (Rash)
12/2006 - 08/2006

Drug/Important Bio-Agent (IBA)

91Amyloid (Amyloid Fibrils)IBA
01/2022 - 06/2002
50Prealbumin (Transthyretin)IBA
01/2022 - 06/2002
30Proteins (Proteins, Gene)FDA Link
05/2022 - 01/2003
16AA amyloidosisIBA
01/2021 - 09/2002
11Biomarkers (Surrogate Marker)IBA
01/2022 - 10/2012
11Serum Amyloid P-ComponentIBA
01/2018 - 11/2002
10Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA
01/2022 - 07/2003
10Bortezomib (Velcade)FDA Link
04/2021 - 02/2008
10GadoliniumIBA
01/2020 - 11/2008
10Fibrinogen (Factor I)FDA Link
07/2019 - 06/2002
9Blood Proteins (Serum Proteins)IBA
12/2021 - 11/2002
8Pharmaceutical PreparationsIBA
01/2018 - 05/2006
8Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
01/2018 - 02/2004
6Apolipoprotein A-I (Apolipoprotein A1)IBA
05/2022 - 06/2002
6Brain Natriuretic Peptide (Natrecor)FDA Link
01/2022 - 11/2007
6canakinumabFDA Link
01/2021 - 06/2009
6Serum Amyloid A Protein (Serum Amyloid A)IBA
01/2020 - 11/2005
6Dexamethasone (Maxidex)FDA LinkGeneric
01/2020 - 01/2007
6AntibodiesIBA
01/2019 - 11/2005
5CreatinineIBA
05/2022 - 06/2007
5AcidsIBA
01/2022 - 11/2014
5Interleukin-1 (Interleukin 1)IBA
07/2019 - 02/2004
5pyrrolidineIBA
01/2018 - 05/2009
5Carboxylic AcidsIBA
01/2018 - 05/2009
5C-Reactive ProteinIBA
02/2014 - 11/2005
5DNA (Deoxyribonucleic Acid)IBA
02/2013 - 01/2002
4pro-brain natriuretic peptide (1-76)IBA
01/2022 - 04/2013
4patisiranIBA
12/2021 - 08/2013
3InterleukinsIBA
01/2021 - 12/2006
3Immunoglobulin M (IgM)IBA
01/2018 - 11/2008
3Complement System Proteins (Complement)IBA
09/2015 - 04/2006
3Doxycycline (Periostat)FDA LinkGeneric
01/2015 - 06/2013
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2014 - 01/2007
3Thalidomide (Thalomid)FDA Link
09/2014 - 01/2007
3Type I Tumor Necrosis Factor ReceptorsIBA
12/2012 - 01/2002
3Proline (L-Proline)FDA Link
11/2010 - 05/2009
3Interleukin-1beta (Interleukin 1 beta)IBA
05/2009 - 06/2006
2Diflunisal (Dolobid)FDA Link
12/2021 - 01/2015
2Troponin T (Troponin T1)IBA
01/2021 - 01/2013
2Monoclonal AntibodiesIBA
01/2021 - 05/2012
2ColchicineFDA LinkGeneric
01/2021 - 11/2007
2revusiranIBA
12/2020 - 01/2020
2Lenalidomide (CC 5013)FDA Link
01/2020 - 09/2014
2Congo RedIBA
01/2019 - 06/2017
2CytokinesIBA
01/2018 - 01/2011
2miridesapIBA
01/2018 - 01/2018
2AntigensIBA
01/2017 - 06/2006
2ParaproteinsIBA
10/2016 - 02/2006
2RNA (Ribonucleic Acid)IBA
06/2016 - 05/2012
2GelsolinIBA
12/2014 - 06/2014
2Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
01/2011 - 01/2008
2Melphalan (Alkeran)FDA LinkGeneric
11/2007 - 01/2007
2fibrinogen AalphaIBA
03/2007 - 11/2005

Therapy/Procedure

33Therapeutics
01/2022 - 11/2002
16Drug Therapy (Chemotherapy)
01/2021 - 07/2003
7Stem Cell Transplantation
04/2021 - 02/2006
7Liver Transplantation
01/2015 - 03/2004
5Kidney Transplantation
01/2021 - 12/2006
4Transplantation
05/2022 - 03/2007
4Lasers (Laser)
05/2017 - 10/2011
3Transcatheter Aortic Valve Replacement
01/2022 - 01/2018
2RNAi Therapeutics
01/2018 - 08/2013
2Injections
01/2017 - 08/2006
2Heart Transplantation (Grafting, Heart)
02/2006 - 10/2004